ClinicalTrials.gov record
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
ClinicalTrials.gov ID: NCT00537420
Public ClinicalTrials.gov record NCT00537420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-Week, Blinded, Randomized, Placebo-Controlled Dose-Ranging Trial of Nasal PYY3-36 for Weight Loss in Healthy Obese Patients
Study identification
- NCT ID
- NCT00537420
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nastech Pharmaceutical Company, Inc.
- Industry
- Enrollment
- 551 participants
Conditions and interventions
Conditions
Interventions
- Nasal Placebo Drug
- Placebo Capsule Drug
- PYY3-36 Drug
- Sibutramine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Jun 30, 2008
- Completion
- Aug 31, 2008
- Last update posted
- Sep 14, 2008
2007 – 2008
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Peoria | Arizona | 85381 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Phoenix | Arizona | 85050 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Anaheim | California | 92801 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Beverly Hills | California | 90211 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Carmichael | California | 95608 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Orange | California | 92869 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Sacramento | California | 95816 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | San Diego | California | 92108 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | San Diego | California | 92130 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | San Francisco | California | 94102 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Pembroke Pines | Florida | 33024 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Atlanta | Georgia | 30328 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Augusta | Georgia | 30909 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Evansville | Indiana | 47713 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Valparaiso | Indiana | 46383 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Baton Rouge | Louisiana | 70808 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Brooklyn Center | Minnesota | 55430 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Las Vegas | Nevada | 89104 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Manlius | New York | 13104 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Charlotte | North Carolina | 28209 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Raleigh | North Carolina | 27612 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Cleveland | Ohio | 44122 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Reading | Pennsylvania | 19606 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Greer | South Carolina | 29651 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Mt. Pleasant | South Carolina | 29464 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Austin | Texas | 78705 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | San Antonio | Texas | 78229-3894 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Temple | Texas | 76508 | — |
| For additional information regarding investigative sites for this trial, contact 1-425-415-3011 | Salt Lake City | Utah | 84049 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00537420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2008 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00537420 live on ClinicalTrials.gov.